Medium-1331917400
Official

Brian Marckx

Senior Medical Device Analyst

Brian Marckx is the Senior Medical Device Analyst with Zacks Investment Research. Prior to joining Zacks, Brian worked as a high-yield bond analyst on Wachovia Securities' institutional trading desks.

Followers

  1. Thumb-1393994791
    jockinmikeg
    Michael

    Investment Strategy: holding disruptive and monopoly plays - trading biotechs and pennies.
  2. Default_avatar_thumb
    icos6
    xavier

    biotech investor
  3. Thumb-1390953513
    murthy_bw
    murthy y

  4. Thumb-1392025080
    xusnbb
    xusnbb

  5. Thumb-1390671186
    ThinkingAlpha
    ThinkingAlpha

    ThinkingAlpha.com. A Premiere Day Trading Forum Where Active Traders Exchange Ideas to Maximise Profit. info@thinkingalpha.com
  6. Thumb-1356113901
    stockmannick
    Nick Bzovi

    Equity/Options Trader, 11 yrs experience. Special interest in biotech/pharma
  7. Default_avatar_thumb
    cwaves
    Clarence Tse

  8. Default_avatar_thumb
    Bartos390
    Eric Peterson

  9. Thumb-1385958531
    bucbowes
    Tyler Bowes

  10. Thumb-1384223701
    FIRSTMILE
    marta

    Bottom up style. Multi-week >>> long-term focus. CMT L 3 candidate. Making followers aware of big stock moves before they happen.
  11. Thumb-1347254193
    bradloncar
    Brad Loncar

    I tweet about biotech on Twitter, everything else on StockTwits.
  12. Thumb-1367825517
    kamenr
    Scott Mason

  13. Default_avatar_thumb
    BioTerp
    Zack

  14. Default_avatar_thumb
  15. Thumb-1379691928
    TacticalQuant
    tactical

    Quantitative analysis and statistical arbitrage research
  16. Default_avatar_thumb
    Mandrake
    Vik

  17. Default_avatar_thumb
    MrVl
    Maxim

  18. Default_avatar_thumb
    WatImFinkin
    ♔✈ ZΑⓒK™

  19. Default_avatar_thumb
    robertledz
    Robert Vasquez

  20. Default_avatar_thumb
    sbpsak
    Bob Case

Also With Zacks Small Cap Research

Disclosure

Zacks SCR certifies that all of the views expressed in our reports or blogs accurately reflect the personal views of the analyst or analysts contributing to the report or blog about the subject company or... more